| ²é¿´: 594 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
liuyuanzuo½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖú£¬ÁÙ´²ÊÔÑé·Òë
|
|
|
According to Article 1(3) of Directive 2005/28/EC a specific modality related to handling of investigational medicinal products where provisions laid down by Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) are not practicable may be accepted. Therefore, a sponsor may put in place arrangements with the pharmacist and the investigator to ensure, as far as possible, that specific accountability procedures and records for the trial been adopted. This includes documentation in the patient¡¯s medical chart or other source document, e.g. the patient¡¯s diary, and/or the case report form. The pharmacy's and the investigator¡¯s procedures and records should allow adequate re-construction of investigational medicinal product movements and administration, having regard to the purpose of the trial. It should at least include a procedure to record which patients received which investigational medicinal products during the trial with an evaluation of the compliance. |
» ²ÂÄãϲ»¶
26µ÷¼Á 086003
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
271·ÖÇóµ÷¼ÁѧУ
ÒѾÓÐ11È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ8È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö
ÒѾÓÐ15È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ6È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
283Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
huangzx1314
½û³æ (ÖªÃû×÷¼Ò)
- ·ÒëEPI: 67
- Ó¦Öú: 86 (³õÖÐÉú)
- ¹ó±ö: 0.757
- ½ð±Ò: 11361.7
- É¢½ð: 3349
- ºì»¨: 61
- ɳ·¢: 93
- Ìû×Ó: 6716
- ÔÚÏß: 751.3Сʱ
- ³æºÅ: 902171
- ×¢²á: 2009-11-13
- ÐÔ±ð: GG
- רҵ: ÆäËûÎÞ»ú·Ç½ðÊô²ÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
liuyuanzuo: ½ð±Ò+15, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÐÁ¿àÄãÁË£¡£¡·Ç³£¸Ðл£¡ 2013-07-29 08:25:11
liuyuanzuo: ½ð±Ò+15, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ÐÁ¿àÄãÁË£¡£¡·Ç³£¸Ðл£¡ 2013-07-29 08:25:11
|
×Ô¼ºµÄ·Ò룬Íû²ÉÄÉ~~~~ ¸ù¾ÝµÚ1Ìõ(3)2005/28/ECÖ¸ÁҩƷÉú²úÖÊÁ¿¹ÜÀí¹æ·¶£¨GMP£©ºÍÒ©Æ·ÁÙ´²ÊµÑé¹ÜÀí¹æ·¶ÖÐÖ¸³ö²»¿ÉÐеÄÁÙ´²ÊÔÑéÒ©Æ·µÄ¾ßÌåÎïÀíÁÆ·¨ÊǿɽÓÊܵġ£Òò´Ë£¬ÔÞÖúÉÌ¿ÉÄܺÍÒ©¼ÁʦÒÔ¼°µ÷²éÔ±ÍÆ³ö´ëÊ©À´¾¡¿ÉÄܵØÈ·±£¾ßÌåÎÊÔð³ÌÐòºÍ¼Ç¼ÊÔÑéµÄʵʩ¡£µ±ÖаüÀ¨²¡È˲¡ÀúÒÔ¼°ÆäËüÔ´Îĵµ¡£±ÈÈ粡ÈËÈռǺÍ/»òÕß²¡Àú¼Ç¼±í¡£Ò©·¿ºÍµ÷²éÕߵijÌÐòºÍ¼Ç¼Ӧ¸ÃÔÊÐíÁÙ´²ÊÔÑéÒ©Æ·¸ù¾ÝÊÔÑéÄ¿µÄ½øÐе÷ÅäºÍ¹ÜÀí¡£ËüÖÁÉÙÓ¦¸ÃÓÐÒ»¸ö³ÌÐòÀ´¼Ç¼ÔÚÊÔÑé¹ý³ÌÖÐÄÄÒ»¸ö²¡È˽ÓÊÜÁËÄÄÒ»ÖÖÁÙ´²ÊÔÑéÒ©Æ·£¬²¢¶ÔÆä½øÐкϹæÐÔÆÀ¹À¡£ |
2Â¥2013-07-28 16:12:44














»Ø¸´´ËÂ¥